{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:10:30Z","timestamp":1792789830255,"version":"4.5.0"},"reference-count":41,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"NIH\/National Institute of Neurological Disorders and Stroke (NINDS)","doi-asserted-by":"publisher","award":["1R01NS105910"],"award-info":[{"award-number":["1R01NS105910"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NIH\/National Institute of Neurological Disorders and Stroke (NINDS)","doi-asserted-by":"publisher","award":["1R01HL150145"],"award-info":[{"award-number":["1R01HL150145"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NIH\/National Institute of Neurological Disorders and Stroke (NINDS)","doi-asserted-by":"publisher","award":["1R01HL130630"],"award-info":[{"award-number":["1R01HL130630"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NIH\/National Institute of Neurological Disorders and Stroke (NINDS)","doi-asserted-by":"publisher","award":["1SC2GM144168"],"award-info":[{"award-number":["1SC2GM144168"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NIH\/National Institute of Neurological Disorders and Stroke (NINDS)","doi-asserted-by":"publisher","award":["63445-00 51"],"award-info":[{"award-number":["63445-00 51"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NIH\/National Heart Lung and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["1R01NS105910"],"award-info":[{"award-number":["1R01NS105910"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NIH\/National Heart Lung and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["1R01HL150145"],"award-info":[{"award-number":["1R01HL150145"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NIH\/National Heart Lung and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["1R01HL130630"],"award-info":[{"award-number":["1R01HL130630"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NIH\/National Heart Lung and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["1SC2GM144168"],"award-info":[{"award-number":["1SC2GM144168"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NIH\/National Heart Lung and Blood Institute (NHLBI)","doi-asserted-by":"publisher","award":["63445-00 51"],"award-info":[{"award-number":["63445-00 51"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH\/National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"publisher","award":["1R01NS105910"],"award-info":[{"award-number":["1R01NS105910"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH\/National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"publisher","award":["1R01HL150145"],"award-info":[{"award-number":["1R01HL150145"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH\/National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"publisher","award":["1R01HL130630"],"award-info":[{"award-number":["1R01HL130630"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH\/National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"publisher","award":["1SC2GM144168"],"award-info":[{"award-number":["1SC2GM144168"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH\/National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"publisher","award":["63445-00 51"],"award-info":[{"award-number":["63445-00 51"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PSC-CUNY Award cycle 51","award":["1R01NS105910"],"award-info":[{"award-number":["1R01NS105910"]}]},{"name":"PSC-CUNY Award cycle 51","award":["1R01HL150145"],"award-info":[{"award-number":["1R01HL150145"]}]},{"name":"PSC-CUNY Award cycle 51","award":["1R01HL130630"],"award-info":[{"award-number":["1R01HL130630"]}]},{"name":"PSC-CUNY Award cycle 51","award":["1SC2GM144168"],"award-info":[{"award-number":["1SC2GM144168"]}]},{"name":"PSC-CUNY Award cycle 51","award":["63445-00 51"],"award-info":[{"award-number":["63445-00 51"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Cerebral malaria (CM) is the most severe neurological complication of malaria caused by Plasmodium falciparum infection. The available antimalarial drugs are effective at clearing the parasite, but the mortality rate remains as high as 20% of CM cases. At the vascular level, CM is characterized by endothelial activation and dysfunction. Several biomarkers of endothelial activation have been associated with CM severity and mortality, making the brain vascular endothelium a potential target for adjunctive therapies. Statins and Angiotensin II Receptor Blockers (ARBs) are drugs used to treat hypercholesterolemia and hypertension, respectively, that have shown endothelial protective activity in other diseases. Here, we used a combination of a statin (atorvastatin) and an ARB (irbesartan) as adjunctive therapy to conventional antimalarial drugs in a mouse experimental model of CM. We observed that administration of atorvastatin\u2013irbesartan combination decreased the levels of biomarkers of endothelial activation, such as the von Willebrand factor and angiopoietin-1. After mice developed neurological signs of CM, treatment with the combination plus conventional antimalarial drugs increased survival rates of animals 3\u20134 times compared to treatment with antimalarial drugs alone, with animals presenting lower numbers and smaller hemorrhages in the brain. Taken together, our results support the hypothesis that inhibiting endothelial activation would greatly reduce the CM-associated pathology and mortality.<\/jats:p>","DOI":"10.3390\/pathogens11060643","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T11:05:02Z","timestamp":1654167902000},"page":"643","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment Reducing Endothelial Activation Protects against Experimental Cerebral Malaria"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-6283","authenticated-orcid":false,"given":"Sabrina","family":"Mota","sequence":"first","affiliation":[{"name":"Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Bensalel","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Lehman College, The City University of New York, Bronx, New York, NY 10468, USA"},{"name":"Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hee","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8914-7740","authenticated-orcid":false,"given":"Julio","family":"Gallego-Delgado","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Lehman College, The City University of New York, Bronx, New York, NY 10468, USA"},{"name":"Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"ref_1","unstructured":"(2021, December 06). World Malaria Report. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240040496."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1203\/PDR.0b013e3181eee738","article-title":"Cerebral malaria: Mechanisms of brain injury and strategies for improved neurocognitive outcome","volume":"68","author":"Idro","year":"2010","journal-title":"Pediatr. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"829413","DOI":"10.3389\/fcimb.2022.829413","article-title":"Malaria Related Neurocognitive Deficits and Behavioral Alterations","volume":"12","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12936-018-2195-7","article-title":"Adjunctive therapy for severe malaria: A review and critical appraisal","volume":"17","author":"Varo","year":"2018","journal-title":"Malar. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ajpath.2011.01.016","article-title":"The neuropathology of fatal cerebral malaria in malawian children","volume":"178","author":"Schmidt","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Conroy, A.L., Phiri, H., Hawkes, M., Glover, S., Mallewa, M., Seydel, K.B., Taylor, T.E., Molyneux, M.E., and Kain, K.C. (2010). Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: A retrospective case-control study. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015291"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MOH.0b013e328345a4cf","article-title":"Endothelial activation and dysregulation in malaria: A potential target for novel therapeutics","volume":"18","author":"Kim","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/HJH.0b013e328355860e","article-title":"Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome","volume":"30","author":"Kishi","year":"2012","journal-title":"J. Hypertens."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/hr.2010.107","article-title":"Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan","volume":"33","author":"Wago","year":"2010","journal-title":"Hypertens. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"III39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1475-2875-12-302","article-title":"Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model","volume":"12","author":"Dormoi","year":"2013","journal-title":"Malar. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1172\/JCI87306","article-title":"Angiotensin receptors and beta-catenin regulate brain endothelial integrity in malaria","volume":"126","author":"Ty","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2875-10-52","article-title":"Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage","volume":"10","author":"Taoufiq","year":"2011","journal-title":"Malar. J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Reis, P.A., Estato, V., da Silva, T.I., d\u2019Avila, J.C., Siqueira, L.D., Assis, E.F., Bozza, P.T., Bozza, F.A., Tibirica, E.V., and Zimmerman, G.A. (2012). Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003099"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2875-11-13","article-title":"Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model","volume":"11","author":"Souraud","year":"2012","journal-title":"Malar. J."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wilson, N.O., Solomon, W., Anderson, L., Patrickson, J., Pitts, S., Bond, V., Liu, M., and Stiles, J.K. (2013). Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060898"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.21037\/atm.2016.11.03","article-title":"Treating the host response to emerging virus diseases: Lessons learned from sepsis, pneumonia, influenza and Ebola","volume":"4","author":"Fedson","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1517\/14656566.2015.1019464","article-title":"Renin-angiotensin system inhibitor and statins combination therapeutics\u2014What have we learnt?","volume":"16","author":"Koh","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.01330-06","article-title":"Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum","volume":"51","author":"Pradines","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.mayocp.2013.06.012","article-title":"Etiology and therapeutic approach to elevated lactate levels","volume":"88","author":"Andersen","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_21","first-page":"261","article-title":"Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria","volume":"12","author":"Consten","year":"2005","journal-title":"J. Travel Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cis733","article-title":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes","volume":"55","author":"Mortensen","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1164\/rccm.201602-0368OC","article-title":"Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients","volume":"194","author":"Scicluna","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/cc13828","article-title":"Effect of statin therapy on mortality from infection and sepsis: A meta-analysis of randomized and observational studies","volume":"18","author":"Wan","year":"2014","journal-title":"Crit. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2008.04.010","article-title":"Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo","volume":"202","author":"Dasu","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00134-009-1545-x","article-title":"Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats","volume":"35","author":"Hagiwara","year":"2009","journal-title":"Intensive Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bcp.2014.11.013","article-title":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications","volume":"93","author":"Tikoo","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Xiao, H., Qin, X., Ping, D., and Zuo, K. (2013). Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059233"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fcimb.2015.00075","article-title":"Pathogenesis of cerebral malaria: New diagnostic tools, biomarkers, and therapeutic approaches","volume":"5","author":"Sahu","year":"2015","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1400116","article-title":"Brain swelling and death in children with cerebral malaria","volume":"372","author":"Seydel","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Craig, A.G., Grau, G.E., Janse, C., Kazura, J.W., Milner, D., Barnwell, J.W., Turner, G., Langhorne, J., and on behalf of the participants of the Hinxton Retreat meeting on \u201cAnimal Models for Research on Severe Malaria\u201d (2012). The role of animal models for research on severe malaria. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002401"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S0031182009991715","article-title":"Cerebral malaria: Why experimental murine models are required to understand the pathogenesis of disease","volume":"137","author":"Hafalla","year":"2010","journal-title":"Parasitology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Phiri, H.T., Bridges, D.J., Glover, S.J., van Mourik, J.A., de Laat, B., M\u2019Baya, B., Taylor, T.E., Seydel, K.B., Molyneux, M.E., and Faragher, E.B. (2011). Elevated plasma von Willebrand factor and propeptide levels in Malawian children with malaria. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025626"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"358ra128","DOI":"10.1126\/scitranslmed.aaf6812","article-title":"Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria","volume":"8","author":"Higgins","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e12641","DOI":"10.1002\/rth2.12641","article-title":"The von Willebrand factor\u2014ADAMTS-13 axis in malaria","volume":"6","author":"Fazavana","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1475-2875-9-227","article-title":"Artemisone effective against murine cerebral malaria","volume":"9","author":"Hunt","year":"2010","journal-title":"Malar. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/02664763.2010.498507","article-title":"Measuring effect size: A robust heteroscedastic approach for two or more groups","volume":"38","author":"Wilcox","year":"2011","journal-title":"J. Appl. Stat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/biomet\/61.1.165","article-title":"The two-sample trimmed t for unequal population variances","volume":"61","author":"Yuen","year":"1974","journal-title":"Biometrika"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"R Core Team (2017). A Language and Environment for Statistical Computing, Foundation for Statistical Computing. R Version 3.5.1R.","DOI":"10.1201\/9780203758212-1"},{"key":"ref_40","unstructured":"Mair, P., Schoenbrodt, F., and Wilcox, R. (2022, May 04). WRS2: Wilcox Robust Estimation and Testing. Available online: https:\/\/cran.r-project.org\/web\/packages\/WRS2\/index.html."},{"key":"ref_41","unstructured":"Dardis, C. (2022, May 04). survMisc: Miscellaneous Functions for Survival Data. Available online: https:\/\/CRAN.R-project.org\/package=survMisc."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/6\/643\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:24:00Z","timestamp":1760138640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/6\/643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["pathogens11060643"],"URL":"https:\/\/doi.org\/10.3390\/pathogens11060643","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]}}}